Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Asuka Masumoto"'
Autor:
Masaki Ohya, Tomohiro Sonou, Kouji Okuda, Shigeo Negi, Yuri Nakashima, Yuko Iwashita, Toru Mima, Asuka Masumoto, Takashi Shigematsu, Mitsuru Yashiro
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Aim: Vascular calcification (VC) is a risk factor of cardiovascular and all-cause mortality in patients with chronic kidney disease (CKD). CKD–mineral and bone metabolism disorder is an important problem in patients with renal failure. Abnormal lev
Autor:
Yoshiyuki Hanba, Yuri Nakashima, Tomohiro Sonou, Koichi Tatsuta, Daisuke Koreeda, Mitsuru Yashiro, Mari Moribata, Shintaro Yamanaka, Toru Mima, Takashi Shigematsu, Shigeo Negi, Asuka Masumoto, Masaki Ohya
Publikováno v:
Growth Factors. 34:196-202
The FGF23-Klotho signaling axis is known to exert anti-aging effects via calcium-phosphorus metabolism. In mice deficient in FGF23-Klotho signaling, however, the number of splenocytes is reduced. FGF23 is expressed in both bone and spleen, with regul
Autor:
Asuka Masumoto, Hiromi Kimura-Suda, Toru Mima, Takashi Shigematsu, Yuri Nakashima, Mitsuru Yashiro, Teppei Ito, Shigeo Negi, Masaki Ohya, Tomohiro Sonou
Publikováno v:
Journal of Atherosclerosis and Thrombosis. 22:1197-1206
Aim High phosphorus conditions promote vascular calcification (VC) in both chronic kidney disease (CKD) patients and experimental models. However, the composition of medial calcification has not been accurately determined, so the objective of this st
Autor:
Wataru Yoshimoto, Takurou Yano, Mari Moribata, Asuka Masumoto, Takashi Shigematsu, Shintaro Yamanaka, Koichi Tatsuta, Toshifumi Sakaguchi, Daisuke Koreeda, Yoshiyuki Hanba, Yuri Nakashima, Yusuke Tanaka, Toru Mima, Shuto Yamamoto, Shigeo Negi, Sou Kobayashi, Koji Masumoto, Masaki Ohya
Publikováno v:
Internal Medicine. 54:2207-2211
A 29-year-old woman was diagnosed with Henoch-Schönlein purpura nephritis (HSPN) based on the presence of purpura and histopathological findings showing crescent formation, mesangial proliferation and IgA deposition in the glomerular mesangium. She
Autor:
Takashi Shigematsu, Hiraku Yoshida, Masaki Ohya, Satoko Kunimoto, Yuko Iwashita, Kouji Okuda, Asuka Masumoto, Takashi Yokoo, Tomohiro Sonou, Keitaro Yokoyama, Yukiko Yamano, Keiko Iseki
Background: Vascular calcification is significant because of the close association between the degree of vascular calcification and cardiovascular mortality in chronic kidney disease (CKD) patients. Summary: There are 2 types of vascular calcificatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2f9d289044ca0450ed095044494048f
https://doi.org/10.1159/000452310
https://doi.org/10.1159/000452310
Autor:
Masaki Ohya, Shigeo Negi, Yuri Nakashima, Mitsuru Yashiro, Tomohiro Sonou, Takashi Shigematsu, Toru Mima, Asuka Masumoto, Teppei Ito, Hiromi Kimura-Suda
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 40(6)
Previous clinical and experimental studies have indicated that magnesium may prevent vascular calcification (VC), but mechanistic characterization has not been reported. This study investigated the influence of increasing magnesium concentrations on
Publikováno v:
Tetrahedron: Asymmetry. 23:205-208
Calixarene-like chiral salen macrocycles can be used for the enantioselective fluorescent recognition of mandelic acid derivatives. It was observed that one enantiomer of mandelic acid causes a 28-fold increase in the fluorescence intensity of a chir
Autor:
Masaki Ohya, Yuri Nakashima, Shigeo Negi, Maki Ohura, Toru Mima, Takashi Shigematsu, Asuka Masumoto
Publikováno v:
Renal Replacement Therapy. 1
Perirenal hematomas are most frequently caused by neoplasm, followed by polyarteritis nodosa (PN), but may also be a rare complication of MPA. A 77-year-old woman who presented with rapidly progressive glomerulonephritis, proteinuria, and mononeuropa
Autor:
Shintaro Yamanaka, Yuri Nakashima, Masaki Ohya, Toru Mima, Mari Moribata, Shigeo Negi, Asuka Masumoto, Takashi Shigematsu, Kouichi Tatsuta, Yuka Iwatani
In end-stage renal disease patients, various abnormalities of bone mineral metabolism adversely affect mortality. Hyperphosphatemia is known to adversely affect mortality and quality of life in chronic kidney disease patients and has been shown to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85186940940f7bb8675942c4bfc78cb5
https://doi.org/10.1159/000380969
https://doi.org/10.1159/000380969
Publikováno v:
Clinical calcium. 22(7)
Hyperphosphatemia is a serious complication which has been linked with an increased risk of cardiovascular mortality in patients with chronic kidney disease. Especially in end stage renal disease (ESRD) patients, the nutritional disturbance due to st